Vaginal and vulval cancers Key Facts
Key messages on incidence, survival, mortality, risk factors (causes) and a summary table of the statistics for vaginal and vulval cancers are given here.
More comprehensive information and statistics for vaginal cancer is here: incidence, survival, mortality and risk factors.
More comprehensive information and statistics for vulval cancer is here: incidence, survival, mortality and risk factors.
- Download these Key Facts Vaginal and vulval cancers Key Facts
The latest statistics available for vaginal and vulval cancers are; incidence 2010, mortality 2010, and survival 1996-1999. Source years are specified in the statistics table. Find out why these are the latest statistics available.
- In 2010, around 280 women were diagnosed with vaginal cancer and around 1,200 women were diagnosed with vulval cancer. Together that is around 4 every day.
- Vaginal cancer is a rare cancer in the UK, accounting for around 1% of all gynaecological cancers. Vulval cancer accounts for around 6% of all gynaecological cancers diagnosed in the UK.
- Incidence of vaginal and vulval cancer increases with age. The highest rates are in women aged over 65 years.
Read more in-depth vaginal cancer incidence and vulval cancer incidence statistics.
section reviewed 14/01/13
section updated 14/01/13
- Around three-quarters of women diagnosed with vaginal or vulval cancer survive their disease for at least one year after diagnosis.
- Around 6 in 10 women diagnosed with vaginal or vulval cancer survive their disease for at least five years after diagnosis.
Read more in-depth vaginal cancer survival and vulval cancer survival statistics.
section reviewed 22/02/13
section updated 10/07/12
- In 2010 around 90 women died from vaginal cancer, and around 410 died from vulval cancer. Together that is around 1 every day.
- Vulval and vaginal cancer mortality is declining. Rates have more than halved in the last 40 years.
Read more in-depth vaginal cancer mortality and vulval cancer mortality statistics.
section reviewed 22/02/13
section updated 10/07/12
- Infection with the human papillomavirus (HPV) increases risk of vaginal cancer and vulval cancer, and their associated pre-cancerous lesions.
- Women with HIV or those treated with drugs to suppress the immune system may have an increased risk of vaginal cancer and vulval cancer.
- Women whose mothers were treated with the drug diethylstilboestrol (DES), a medication given to prevent miscarriage in the 1940s-1960s, have an increased risk of vaginal cancer.
Read more in-depth vaginal cancer risk factors and vulval cancer risk factors.
section reviewed 22/02/13
section updated 10/07/12
| VAGINAL AND VULVAL CANCER STATISTICS | Females | Country | Year3 |
| Number of new cases per year - vaginal cancer | 281 | UK | 2010 |
| Incidence rate per 100,000 population1 | 0.6 | ||
| Number of new cases per year - vulval cancer | 1,172 | UK | 2010 |
| Incidence rate per 100,000 population1 | 2.5 | ||
| Number of deaths per year - vaginal cancer | 86 | UK | 2010 |
| Mortality rate per 100,000 population1 | 0.2 | ||
| Number of deaths per year - vulval cancer | 410 | UK | 2010 |
| Mortality rate per 100,000 population1 | 0.7 | ||
| One-year survival rate - vaginal & vulval cancer2 | 76.4% | England & Wales |
1996-1999 |
| Five-year survival rate - vaginal & vulval cancer2 | 58.0% |
1. European age-standardised 2. Adults diagnosed 3. Latest statistics available
More detailed vaginal cancer statistics can be found using these links: incidence, survival, mortality and risk factors.
section reviewed 22/02/13
section updated 14/01/13






Read press release

